Apr 11 • General discussion
How an Experiment Tried to Turn Off the Muscle’s “Brake”
The human body is not designed for unlimited growth.
There is a molecular system whose purpose is exactly that: to impose a limit.
At the center of this system is a protein known as 🔵myostatin (GDF-8)🔵.
Its role is straightforward:to inhibit skeletal muscle hypertrophy.
How it works under normal conditions
Myostatin binds to a receptor on the surface of muscle cells called ActRIIB.
This interaction activates an intracellular signaling pathway:
🔴SMAD2/3🔴
The outcome is a clear biological signal:reduce muscle cell growth and differentiation.
This is a regulatory mechanism, not a defect.
What ACE-031 does
ACE-031 is a recombinant fusion protein engineered to interfere with this process.
Instead of blocking the receptor at the cellular level, it operates differently:
it circulates in the bloodstream and functions as a soluble decoy receptor.
This means it binds myostatin before it can reach its natural receptor.
What happens at the molecular level
When myostatin is sequestered:
⚠️it cannot bind to ActRIIB
⚠️SMAD2/3 signaling is not activated
⚠️the inhibitory signal is effectively removed
The result is a physiological environment more permissive to muscle growth.
The critical detail
ACE-031 is not selective for myostatin.
It also binds other ligands within the same signaling network, including:
- activins
- members of the BMP family, such as BMP-9
These molecules are not limited to muscle regulation.
They also play key roles in vascular homeostasis and endothelial signaling.
1
2 comments
How an Experiment Tried to Turn Off the Muscle’s “Brake”
powered by
skool.com/antiet-1213
Welcome to Pharmacology Systems!In this course, we’ll guide you to grasp core pharmacology knowledge and help you apply it properly
Suggested communities
Powered by